Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
暂无分享,去创建一个
W. Lee | J. Oh | C. Yu | Hyeong-Rok Kim | N. Kim | G. Choi | K. Lee | Seon-Han Kim | Jung Bok Lee | I. Park | D. Kim | Seok-Byung Lim | Hee-Cheol Kim | S. Oh | Sun Young Kim | Sung-Bum Kang | J. C. Kim | Sung-Bum Kang | Sung-Bum Kang
[1] Joon-Oh Park,et al. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. , 2014, The Lancet. Oncology.
[2] Jong Hoon Kim,et al. Prognostic Implications of the Number of Retrieved Lymph Nodes of Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy , 2014, Journal of Gastrointestinal Surgery.
[3] L. Collette,et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. , 2014, The Lancet. Oncology.
[4] M. Kalady,et al. Is Adjuvant Chemotherapy Really Needed After Curative Surgery for Rectal Cancer Patients Who are Node-Negative After Neoadjuvant Chemoradiotherapy? , 2012, Annals of Surgical Oncology.
[5] Karin Haustermans,et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.
[6] N. Kim,et al. The Influence of the Number of Retrieved Lymph Nodes on Staging and Survival in Patients With Stage II and III Rectal Cancer Undergoing Tumor-Specific Mesorectal Excision , 2009, Annals of surgery.
[7] C. Capirci,et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. , 2008, International journal of radiation oncology, biology, physics.
[8] M. Gonen,et al. Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiation , 2008, Cancer.
[9] C. Compton. Optimal Pathologic Staging: Defining Stage II Disease , 2007, Clinical Cancer Research.
[10] Heidi Nelson,et al. Discussion: Diagnostic issues in early-stage disease , 2007 .
[11] M. Piérart,et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] C. Horng,et al. Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy? , 2007, Annals of Surgical Oncology.
[13] L. Ellis,et al. Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer , 2006, American journal of clinical oncology.
[14] H. Grönberg,et al. ERRATUM , 2006 .
[15] Rainer Fietkau,et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] A. Morris,et al. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. , 2005, International journal of radiation oncology, biology, physics.
[17] Y. Tsunashima,et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[18] W. Hohenberger,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[19] R. James,et al. Randomized clinical trial of adjuvant radiotherapy and 5‐fluorouracil infusion in colorectal cancer (AXIS) , 2003, The British journal of surgery.
[20] Cummings Bj. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. , 2002, Techniques in coloproctology.
[21] H. Putter,et al. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands , 2002, The British journal of surgery.
[22] T. Wiggers,et al. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III , 2001, British Journal of Cancer.
[23] L. Ellis,et al. Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer , 2001, American journal of clinical oncology.
[24] U. Dafni,et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] R. Labianca,et al. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial , 1998, The Lancet.
[26] J. Macfarlane,et al. Mesorectal excision for rectal cancer , 1993, The Lancet.
[27] R. Heald,et al. RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.
[28] K. Markou,et al. National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .
[29] L. Collette,et al. Chemotherapy with Preoperative Radiotherapy in Rectal Cancer , 2007 .
[30] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[31] O. Dworak,et al. Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.